Emerging roles of p53 in glial cell function in health and disease

GLIA

Volumn 60, Issue 4, 2012, Pages 515-525

  Jebelli, Joseph D ^a   Hooper, Claudie ^b   Garden, Gwenn A ^c   Pocock, Jennifer M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Glia; Neurodegeneration; p53

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMYLOID BETA PROTEIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCITATORY AMINO ACID; HISTONE ACETYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID; NEUROMODULIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PIFITHRIN ALPHA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; RHO KINASE; RING FINGER PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CYCLE ARREST; CELL FUNCTION; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASES; DNA BINDING; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; FIBROBLAST; GLIA CELL; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER GROWTH; NEUROBLASTOMA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; TELANGIECTASIA;

ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856694610     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22268     Document Type: Article

References (130)

1. Alves da Costa C, Dunys J, Brau F, Wilk S, Cappai R, Checler F. 2006a. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. J Biol Chem 281: 9824-9831.
2. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Boyer N, Kawarai T, Girardot N, St George-Hyslop P, Checler F. 2006b. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26: 6377-6385.
3. Anne SL, Saudou F, Humbert S. 2007. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci 27: 7318-7328.
4. Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A. 2005. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47: 29-41.
5. Biber K, Neumann H, Inoue K, Boddeke HW. 2007. Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci 30: 596-602.
6. Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G, Raff M. 2004. Roles for p53 and p73 during oligodendrocyte development. Development 131: 1211-1220.
7. Bishop NA, Lu T, Yankner BA. 2010. Neural mechanisms of ageing and cognitive decline. Nature 464: 529-535.
8. Biswas SC, Ryu E, Park C, Malagelada C, Greene LA. 2005. Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochem Res 30: 839-845.
9. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B. 2004. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: The role of microglia and astrocytes. Aging Cell 3: 169-176.
10. Block ML, Zecca L, Hong JS. 2007. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69.
11. Bonini P, Cicconi S, Cardinale A, Vitale C, Serafino AL, Ciotti MT, Marlier LN. 2004. Oxidative stress induces p53-mediated apoptosis in glia: p53 Transcription-independent way to die. J Neurosci Res 75: 83-95.
12. Bradl M, Lassmann H. 2010. Oligodendrocytes: Biology and pathology. Acta Neuropathol 119: 37-53.
13. Bretaud S, Allen C, Ingham PW, Bandmann O. 2007. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J Neurochem 100: 1626-1635.
14. Brundin P, Melki R, Kopito R. 2010. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11: 301-307.
15. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. 2001. In-vivo measurement of activated microglia in dementia. Lancet 358: 461-467.
16. Carr AM. 2000. Cell cycle. Piecing together the p53 puzzle. Science 287: 1765-1766.
17. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, Bernier G. 2009. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 29: 529-542.
18. Checler F, Dunys J, Pardossi-Piquard R, Alves da Costa C. 2010. p53 is regulated by and regulates members of the gamma-secretase complex. Neurodegener Dis 7: 50-55.
19. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. 2005. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121: 1071-1083.
20. Cheung CC, Yang C, Berger T, Zaugg K, Reilly P, Elia AJ, Wakeham A, You-Ten A, Chang N, Li L, Wan Q, Mak TW. 2010. Identification of BERP (brain-expressed RING finger protein) as a p53 target gene that modulates seizure susceptibility through interacting with GABA(A) receptors. Proc Natl Acad Sci USA 107: 11883-11888.
21. Cheung ZH, Ip NY. 2011. Autophagy deregulation in neurodegenerative diseases-Recent advances and future perspectives. J Neurochem 118: 317-325.
22. Chung YH, Shin CM, Kim MJ, Lee EY, Kim G, Cha CI. 2002. Enhanced expression of p53 in reactive astrocytes following transient focal ischemia. Neurol Res 24: 324-328.
23. Collavin L, Lunardi A, Del Sal G. 2010. p53-family proteins and their regulators: Hubs and spokes in tumor suppression. Cell Death Differ 17: 901-911.
24. Cuesta A, Zambrano A, Royo M, Pascual A. 2009. The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP). Biochem J 418: 643-650.
25. Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, Guyenet SJ, Deller T, Westrum LE, Sopher BL, La Spada AR. 2006. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 9: 1302-1311.
26. da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, Goldberg MS, Shen J, Checler F. 2009. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 11: 1370-1375.
27. Davenport CM, Sevastou IG, Hooper C, Pocock JM. 2010. Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J Neurochem 112: 552-563.
28. Davis DM, Sowinski S. 2008. Membrane nanotubes: Dynamic long-distance connections between animal cells. Nat Rev Mol Cell Biol 9: 431-436.
29. de la Monte SM, Sohn YK, Wands JR. 1997. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152: 73-83.
30. Desai MK, Guercio BJ, Narrow WC, Bowers WJ. 2011. An Alzheimer's disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction. Glia 59: 627-640.
31. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. 2007. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10: 608-614.
32. Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J, Avantaggiati ML, Faden AI. 2006. The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J 25: 4084-4096.
33. Djebaili M, Rondouin G, Baille V, Bockaert J. 2000. p53 and Bax implication in NMDA induced-apoptosis in mouse hippocampus. Neuroreport 11: 2973-2976.
34. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. 2004. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92.
35. Du Y, Yang D, Li L, Luo G, Li T, Fan X, Wang Q, Zhang X, Wang Y, Le W. 2009. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 5: 663-675.
36. Dunys J, Kawarai T, Sevalle J, Dolcini V, George-Hyslop PS, Da Costa CA, Checler F. 2007. p53-Dependent Aph-1 and Pen-2 anti-apoptotic phenotype requires the integrity of the gamma-secretase complex but is independent of its activity. J Biol Chem 282: 10516-10525.
37. Dunys J, Sevalle J, Giaime E, Pardossi-Piquard R, Vitek MP, Renbaum P, Levy-Lahad E, Zhang YW, Xu H, Checler F, da Costa CA. 2009. p53-dependent control of transactivation of the Pen2 promoter by presenilins. J Cell Sci 122: 4003-4008.
38. Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE, Hammers A, Tai YF, Fox N, Kennedy A, Rossor M, Brooks DJ. 2008. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412-419.
39. El Khoury J, Luster AD. 2008. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol Sci 29: 626-632.
40. Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P, Wu M, Wang G. 2008. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283: 4022-4030.
41. Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ. 2006. p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25: 1-7.
42. Fogarty MP, McCormack RM, Noonan J, Murphy D, Gowran A, Campbell VA. 2010. A role for p53 in the beta-amyloid-mediated regulation of the lysosomal system. Neurobiol Aging 31: 1774-1786.
43. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9: 839-855.
44. Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T, Morrison RS. 2004. HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 18: 1141-1143.
45. Garden GA, Moller T. 2006. Microglia biology in health and disease. J Neuroimmune Pharmacol 1: 127-137.
46. Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S. 2010. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 17: 1392-1408.
47. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
48. Gomez-Lazaro M, Galindo MF, Concannon CG, Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH, Jordan J. 2008. 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J Neurochem 104: 1599-1612.
49. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, Chenouard N, de Chaumont F, Martino A, Enninga J, Olivo-Marin JC, Mannel D, Zurzolo C. 2009. Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11: 328-336.
50. Gowran A, Campbell VA. 2008. A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. J Neurochem 105: 1513-1524.
51. Hafiz FB, Brown DR. 2000. A model for the mechanism of astrogliosis in prion disease. Mol Cell Neurosci 16: 221-232.
52. Hainaut P, Hollstein M. 2000. p53 and human cancer: The first ten thousand mutations. Adv Cancer Res 77: 81-137.
53. Hede S-M, Nazarenko I, Nistér M, Lindström MS. 2011. Novel perspectives on p53 function in neural stem cells and brain tumours. J Oncol 2011: 852970.
54. Hooper C, Killick R, Tavassoli M, Melino G, Lovestone S. 2006. TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanism. Neurosci Lett 401: 30-34.
55. Hooper C, Meimaridou E, Tavassoli M, Melino G, Lovestone S, Killick R. 2007. p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. Neurosci Lett 418: 34-37.
56. Hooper C, Fry VAH, Sevastou IG, Pocock JM. 2009. Scavenger receptor control of microglial stress and neurotoxic cascades induced by chromogranin A. FEBS Lett 583: 3461-3466.
57. Hooper C, Pinteaux-Jones F, Fry VAH, Sevastou I, Baker D, Heales SJ, Pocock JM. 2009. Differential effects of albumin on microglia and macrophages: Implications for neurodegeneration following blood-brain barrier damage. J Neurochem. 109: 694-705.
58. Huang C, Wahlund LO, Svensson L, Winblad B, Julin P. 2002. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2: 9.
59. Jacobs WB, Kaplan DR, Miller FD. 2006. The p53 family in nervous system development and disease. J Neurochem 97: 1571-1584.
60. Jayadev S, Nesser NK, Hopkins S, Myers SJ, Case A, Lee RJ, Seaburg LA, Uo T, Murphy SP, Morrison RS, Garden GA. 2011. Transcription factor p53 influences microglial activation phenotype. Glia 59: 1402-1413.
61. Jayadev S, Yun B, Nguyen H, Yokoo H, Morrison RS, Garden GA. 2007. The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. J Neuroimmune Pharmacol 2: 359-370.
62. Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C. 2007. HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. J Neurosci 27: 3703-3711.
63. Jordan-Sciutto KL, Wang G, Murphy-Corb M, Wiley CA. 2000. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am J Pathol 157: 497-507.
64. Kim H-T, Tasca S, Qian W, Wong PKY, Stoica G. 2002. Induction of p53 accumulation by Moloney murie leukemaia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2. Lab Invest 82: 693-702.
65. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. 1997. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 232: 418-421.
66. Kruse JP, Gu W. 2009. Modes of p53 regulation. Cell 137: 609-622.
67. Ladiwala U, Li H, Antel JP, Nalbantoglu J. 1999. p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes. J Neurochem 73: 605-611.
68. Lane DP. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16.
69. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. 1995. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89: 35-41.
70. Lau D, Bading H. 2009. Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J Neurosci 29: 4420-4429.
71. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. 2003. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112: 779-791.
72. Li J, Ghiani CA, Kim JY, Liu A, Sandoval J, DeVellis J, Casaccia-Bonnefil P. 2008. Inhibition of p53 transcriptional activity: A potential target for future development of therapeutic strategies for primary demyelination. J Neurosci 28: 6118-6127.
73. Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, Wang Y, Chase TN, Bennett MC, Qin ZH. 2007. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Res 1145: 190-203.
74. Lo SZ, Steer JH, Joyce DA. 2011. TNFα renders macrophages resistant to a range of cancer chemotherapeutic agents through NF-κB-mediated antagonism of apoptosis signalling. Cancer Lett 307: 80-92.
75. Lobsiger CS, Cleveland DW. 2007. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10: 1355-1360.
76. Ma L, Ohyagi Y, Miyoshi K, Sakae N, Motomura K, Taniwaki T, Furuya H, Takeda K, Tabira T, Kira J. 2009. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors. J Alzheimers Dis 16: 565-575.
77. Martin LJ, Liu Z. 2002. Injury-induced spinal motor neuron apoptosis is preceded by DNA single-strand breaks and is p53- and Bax-dependent. J Neurobiol 50: 181-197.
78. McCoy MK, Tansey MG. 2008. TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5: 45.
79. McGeer EG, McGeer PL. 2010. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: A field in its infancy. J Alzheimers Dis 19: 355-361.
80. McQualter JL, Bernard CC. 2007. Multiple sclerosis: A battle between destruction and repair. J Neurochem 100: 295-306.
81. Morel M, Couturier J, Pontcharraud R, Gil R, Fauconneau B, Paccalin M, Page G. 2009. Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: Role of p53, Redd1 and TSC2. Neurobiol Dis 36: 151-161.
82. Morris LG, Veeriah S, Chan TA. 2010. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 29: 3453-3464.
83. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. 1996. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16: 1337-1345.
84. Mukerjee R, Claudio PP, Chang JR, Del Valle L, Sawaya BE. 2010. Transcriptional regulation of HIV-1 gene expression by p53. Cell Cycle 9: 4569-4578.
85. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. 2007. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-622.
86. Nair VD. 2006. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Apoptosis 11: 955-966.
87. Napieralski JA, Raghupathi R, McIntosh TK. 1999. The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res Mol Brain Res 71: 78-86.
88. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
89. Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, Dickie P, Baker G, Hollenberg MD, Cohen EA, Power C. 2010. MicroRNA profiling reveals new aspects of HIV neurodegeneration: Caspase-6 regulates astrocyte survival. FASEB J 24: 1799-1812.
90. O'Connor JC, Wallace DM, O'Brien CJ, Cotter TG. 2008. A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell. Invest Ophthalmol Vis Sci 49: 4237-4244.
91. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H, Ikezoe K, Furuya H, Kawarabayashi T, Shoji M, Checler F, Iwaki T, Makifuchi T, Takeda K, Kira J, Tabira T. 2005. Intracellular Abeta42 activates p53 promoter: A pathway to neurodegeneration in Alzheimer's disease. FASEB J 19: 255-257.
92. Okuda Y, Okuda M, Bernard CC. 2003. Regulatory role of p53 in experimental autoimmune encephalomyelitis. J Neuroimmunol 135: 29-37.
93. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. 2004. TP53 mutation spectra and load: A tool for generating hypotheses on the etiology of cancer. IARC Sci Publ 247-270.
94. Panickar KS, Jayakumar AR, Rao KV, Norenberg MD. 2009. Ammonia-induced activation of p53 in cultured astrocytes: role in cell swelling and glutamate uptake. Neurochem Int 55: 98-105.
95. Perier C, Bove J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M. 2007. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci USA 104: 8161-8166.
96. Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. 2010. Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet 6: e1001257.
97. Pocock JM, Kettenmann H. 2007. Neurotransmitter receptors on microglia. Trends Neurosci 30: 527-535.
98. Qin L, Liu Y, Cooper C, Liu B, Wilson B, Hong JS. 2002. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83: 973-983.
99. Qin Q, Baudry M, Liao G, Noniyev A, Galeano J, Bi X. 2009. A novel function for p53: Regulation of growth cone motility through interaction with Rho kinase. J Neurosci 29: 5183-5192.
100. Qin Q, Liao G, Baudry M, Bi X. 2010. Role of calpain-mediated p53 truncation in semaphorin 3A-induced axonal growth regulation. Proc Natl Acad Sci USA 107: 13883-13887.
101. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN. 1999. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci 19: 4023-4033.
102. Raivich G. 2005. Like cops on the beat: The active role of resting microglia. Trends Neurosci 28: 571-573.
103. Rodriguez JJ, Witton J, Olabarria M, Noristani HN, Verkhratsky A. 2010. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis 1: e1.
104. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. 2011. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470: 359-365.
105. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 91: 7525-7529.
106. Sanz E, Quintana A, Battaglia V, Toninello A, Hidalgo J, Ambrosio S, Valoti M, Marco JL, Tipton KF, Unzeta M. 2008. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells. J Neurochem 105: 2404-2417.
107. Seifert G, Schilling K, Steinhauser C. 2006. Astrocyte dysfunction in neurological disorders: A molecular perspective. Nat Rev Neurosci 7: 194-206.
108. Sherr CJ, Weber JD. 2000. The ARF/p53 pathway. Curr Opin Genet Dev 10: 94-99.
109. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. 2005. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171: 1001-1012.
110. Silva C, Zhang K, Tsutsui S, Holden JK, Gill MJ, Power C. 2003. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann Neurol 54: 605-614.
111. Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, Pritchard J, Kooperberg C, Olson JM, Cattaneo E. 2002. Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 11: 1953-1965.
112. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119: 7-35.
113. Sondag CM, Dhawan G, Combs CK. 2009. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 6: 1.
114. Speidel D. 2010. Transcription-independent p53 apoptosis: An alternative route to death. Trends Cell Biol 20: 14-24.
115. Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM. 2000. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97: 6763-6768.
116. Streit WJ. 2005. Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev 48: 234-239.
117. Tedeschi A, Nguyen T, Puttagunta R, Gaub P, Di Giovanni S. 2009. A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration. Cell Death Differ 16: 543-554.
118. Trapp BD, Nave KA. 2008. Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31: 247-269.
119. van der Knaap MS, Pronk JC, Scheper GC. 2006. Vanishing white matter disease. Lancet Neurol 5: 413-423.
120. Vaseva AV, Moll UM. 2009. The mitochondrial p53 pathway. Biochim Biophys Acta 1787: 414-420.
121. Villapol S, Acarin L, Faiz M, Castellano B, Gonzalez B. 2007. Distinct spatial and temporal activation of caspase pathways in neurons and glial cells after excitotoxic damage to the immature rat brain. J Neurosci Res 85: 3545-3556.
122. Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
123. Vousden KH, Prives C. 2009. Blinded by the light: The growing complexity of p53. Cell 137: 413-431.
124. Wang Y, Cui J, Sun X, Zhang Y. 2011. Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ 18: 732-742.
125. Wang Y, Dong XX, Cao Y, Liang ZQ, Han R, Wu JC, Gu ZL, Qin ZH. 2009. p53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms. Eur J Neurosci 30: 2258-2270.
126. Watanabe H, Ohta S, Kumon Y, Sakaki S, Sakanaka M. 1999. Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat. Brain Res 837: 38-45.
127. Wosik K, Antel J, Kuhlmann T, Bruck W, Massie B, Nalbantoglu J. 2003. Oligodendrocyte injury in multiple sclerosis: A role for p53. J Neurochem 85: 635-644.
128. Yung HW, Bal-Price AK, Brown GC, Tolkovsky AM. 2004. Nitric oxide-induced cell death of cerebrocortical murine astrocytes is mediated through p53- and Bax-dependent pathways. J Neurochem 89: 812-821.
129. Zhang SJ, Steijaert MN, Lau D, Schutz G, Delucinge-Vivier C, Descombes P, Bading H. 2007. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53: 549-562.
130. Zhang XD, Wang Y, Zhang X, Han R, Wu JC, Liang ZQ, Gu ZL, Han F, Fukunaga K, Qin ZH. 2009. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. Autophagy 5: 339-350.